Form 4: Cargo Therapeutics Director Acquires Stock Options
SEC Form 4 Filing
Kapil Dhingra, a director at Cargo Therapeutics, acquired stock options for 49,265 shares at an exercise price of $19.89 on April 15, 2024.
Summary
- On April 15, 2024, Kapil Dhingra, a director of CARGO Therapeutics, Inc., acquired stock options for 49,265 shares.
- The exercise price for these options is $19.89 per share.
- The options vest monthly, with full vesting occurring on the third anniversary of the Vesting Commencement Date, April 15, 2024.
- The expiration date for the options is April 14, 2034.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock option grants, which is neutral in sentiment.
Industry Context
This is a standard disclosure related to insider transactions, specifically the granting of stock options to a company director. It's a common practice for aligning the interests of management with those of shareholders.
Stakeholder Impact
- The granting of stock options to a director can align their interests with those of shareholders, potentially incentivizing them to increase company value.
Key Dates
| Date | Description |
|---|---|
| 04/15/2024 | Date of earliest transaction: Kapil Dhingra acquired stock options for 49,265 shares at an exercise price of $19.89; Vesting Commencement Date. |
| 04/14/2034 | Expiration date of the stock options. |
| 04/17/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.